Literature DB >> 14580555

Feeding the machine: mechanisms of proteasome-catalyzed degradation of ubiquitinated proteins.

Craig M Crews1.   

Abstract

The proteasome plays a role in a myriad of intracellular processes from cell-cycle control to antigen presentation. Central to these processes is the targeting of selected proteins for proteasomal degradation via their conjugation to ubiquitin. The mechanisms by which the ubiquitin-dependent proteasomal proteolysis occurs can be divided into four steps: first, substrate protein recognition by its cognate E3 ubiquitin ligase; second, polyubiquitinated protein substrate recruitment to the proteasome; third, protein substrate deubiquitination; and four, proteolytic chamber pore opening/substrate translocation followed by proteolysis. Recent advances include the identification of novel E3 ubiquitin ligase recognition determinants, a new isopeptidase activity, and a better understanding of how the proteasome's axial channels are gated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580555     DOI: 10.1016/j.cbpa.2003.08.002

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  10 in total

Review 1.  Chemical approaches to controlling intracellular protein degradation.

Authors:  John S Schneekloth; Craig M Crews
Journal:  Chembiochem       Date:  2005-01       Impact factor: 3.164

Review 2.  Roles of E3 ubiquitin ligases in cell adhesion and migration.

Authors:  Cai Huang
Journal:  Cell Adh Migr       Date:  2010-01-18       Impact factor: 3.405

3.  Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.

Authors:  Claire Maudet; Matthieu Bertrand; Erwann Le Rouzic; Hichem Lahouassa; Diana Ayinde; Sébastien Nisole; Caroline Goujon; Andrea Cimarelli; Florence Margottin-Goguet; Catherine Transy
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

4.  Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10.

Authors:  Nick D Tsihlis; Chris S Oustwani; Ashley K Vavra; Qun Jiang; Larry K Keefer; Melina R Kibbe
Journal:  Cell Biochem Biophys       Date:  2011-06       Impact factor: 2.194

Review 5.  Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy.

Authors:  James J Driscoll; Roopa Dechowdhury
Journal:  Target Oncol       Date:  2010-11-27       Impact factor: 4.493

6.  Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature.

Authors:  Nick D Tsihlis; Muneera R Kapadia; Ashley K Vavra; Walker D Flannery; Christopher S Oustwani; Qun Jiang; Melina R Kibbe
Journal:  J Vasc Surg       Date:  2013-01-30       Impact factor: 4.268

Review 7.  The robotic mouse: understanding the role of AF4, a cofactor of transcriptional elongation and chromatin remodelling, in purkinje cell function.

Authors:  Emmanuelle Bitoun; Kay E Davies
Journal:  Cerebellum       Date:  2009-04-02       Impact factor: 3.847

Review 8.  α-Synuclein and protein degradation systems: a reciprocal relationship.

Authors:  Maria Xilouri; Oystein Rod Brekk; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2012-09-02       Impact factor: 5.590

9.  Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment.

Authors:  Peiyuan Zhang; Xiaohui Liu; Daniel Abegg; Toru Tanaka; Yuquan Tong; Raphael I Benhamou; Jared Baisden; Gogce Crynen; Samantha M Meyer; Michael D Cameron; Arnab K Chatterjee; Alexander Adibekian; Jessica L Childs-Disney; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2021-08-13       Impact factor: 16.383

10.  Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines.

Authors:  Merlis P Alvarez-Berríos; Amalchi Castillo; Carlos Rinaldi; Madeline Torres-Lugo
Journal:  Int J Nanomedicine       Date:  2013-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.